Let’s review the ’24FY Reporting Season Winners by examining the top-performing ASX300 stocks from the past 30 days.
’24FY Reporting Season Winners Current Fundamental Performance
ASX Code | ’24 Revenue Growth | ’24 EBITDA Growth | ’25 EBITDA Growth Estimate | ’25 PER Estimate | Comment |
---|---|---|---|---|---|
WTC | 27.5% | 28.5% | 38.2% | 101 | Upbeat result |
REG | 24.6% | 28.7% | 13.1% | 31 | Result was a beat |
ACL | -0.1% | 3.4% | 5.9% | 17 | Worst over? Start of upgrade cycle? |
ORA | 9.5% | 39% | 17.5% | 16 | Packaging is usually boring but these guys are going well |
LRS | N/A | N/A | N/A | N/A | Received a takeover offer |
MAF | 8.6% | 9.4% | 32.2% | 14 | Still looks cheap if it can deliver on lofty expectations |
PDI | N/A | N/A | N/A | N/A | Takeover speculation |
JBH | -0.4% | -11% | 3.5% | 20 | Not sure why this result was so well received |
JDO | 12.4% | 11.2% | 9.8% | 23 | They keep doing what they say they will |
HLS | 2.3% | -7.9% | 12.4% | 57 | Worst over? Start of upgrade cycle? |
BXB | 7.7% | 8.0% | 6.7% | 29 | Solid but no value here |
CDA | 20.6% | 25.9% | 17.6% | 28 | A strong gold price is good for business |
IMU | N/A | N/A | N/A | N/A | Tiny stock bouncing off the bottom |
TPW | 25.7% | -11.4% | 20.9% | 163 | The good thing about a 11% fall in EBITDA is it’s easier to beat it next year! |
MYX | 111.6% | -VE to +VE | 158.7% | -VE | The recovery is really starting to get going |
INR | N/A | N/A | N/A | 54 | Tiny stock bouncing off the bottom |
ZIP | 23.8% | -VE to +VE | 90.7% | N/A | Increasing scale is starting to pay off |
CTT | 78.3% | 10.8% | 11.3% | 23 | Founder buying, short squeeze – auditor yet to sign-off on accounts |
BRG | 3.5% | 12.5% | 9.5% | 36 | Quality result in tricky market |
BGA | 4.3% | 2.4% | 18.8% | 29 | Strong outlook, but can they deliver? |
Final thoughts
Most stocks on this list are included based on merit, having reported strong results in August with a positive outlook. A few, like INR and PDI, are included on more speculative grounds. Some stocks, such as MYX, ACL, and HLS, appear to be turning things around after challenging years. Others, like JBH and BRG, have been rewarded for producing solid results in a difficult environment. While some stocks seem too expensive on a PER basis to buy today, others still offer value. Overall, it’s a very interesting and diverse list of companies with no one sector being favoured.
Disclaimer: This information is provided purely for educational purposes. It takes no account of an individual’s personal financial circumstances and hence can in no way constitute financial advice. The above data may be subject to errors or inconsistencies for which the author takes no liability. It is imperative that all investors do their own research or if they need advice, seek it from a qualified financial adviser.
’24FY Reporting Season Winners